ArticleInternational journal of biometeorology2025
Neuroimmunomodulation induced by mud-bath therapy: clinical benefits and bioregulation of the innate/inflammatory responses induced by a peloid enriched with rosmarinic acid in elderly patients with osteoarthritis.
Article in International journal of biometeorology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Natural products and immune-cell responses in osteoarthritis: mechanisms, evidence maturity, and translational gaps.Frontiers in immunology · 2026Review
- Hydrogen Sulfide in Balneology: Physiology, Evidence, and Clinical Translation.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Balneotherapy using peloids (mud-bath therapy) is one of the most effective non-pharmacological approaches for managing osteoarticular and musculoskeletal disorders, such as osteoarthritis (OA). Recent studies have shown that peloids enriched with rosmarinic acid (RosA) enhance the therapeutic effects of mud therapy in elderly OA patients. The objective of this study was to evaluate whether the normalization of the interaction between the hormetic stress response, mediated by cortisol, and the inflammatory response, mediated by IL-8 (measured in blood by ELISA), underlies the clinical benefits of a hyperthermic mud-bath intervention using a RosA-enriched peloid, a polyphenolic acid with anti-inflammatory and immunomodulatory properties. Additionally, we aimed to investigate whether this neuroimmune regulation contributes to enhancing the innate immune response, specifically the phagocytic and microbicidal activity of neutrophils (assessed by flow cytometry). Twenty-three elderly OA patients participated in the mud-bath intervention, a 10-day cycle of hyperthermic balneotherapy using a RosA-fortified peloid and mineral medicinal water at 40 °C. Significant increases in systemic cortisol levels, along with a notable decrease in IL-8 and enhanced phagocytic and microbicidal activity of neutrophils, were observed following the intervention. These effects were accompanied by improved knee mobility and reduced pain. In conclusion, hyperthermic mud-bath therapy with a RosA-enriched peloid induces immunoneuroendocrine stabilization, which underlies the clinical benefits of the balneological intervention. Finally, concepts such as neuroimmunomodulation, hormesis, and the bioregulation of the innate and inflammatory immune responses in the context of balneotherapy are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.